The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
That's it Dan, one down!! What a result.
Well done Gareth.....now over to you Nigel!!!
Well you got your first wish John with England getting the better of Germany.
Now it is time for N4 Pharma to step up to the mark.
Take a look at this piece from Leicester on Twitter.
It shows the serious money now flowing into the mRNA sector but also highlights the challenges that mRNA faces in terms of delivery. I have stated many times that Lipids are not suited for mRNA delivery both in terms of toxicity and delivery of RNA into the cell. Nuvec is proven to be non toxic and is well tolerated. It is thermostable at body temperatures and its transfection ability is now proven in-vivo. Nuvec is superior to Lipids in everyway and it is now time for N4 to monetise Nuvec`s superiority and get deals signed.
Time for Nigel to step up to the mark.
https://www.pharmiweb.com/pwtoday-story/sanofi-launches-dedicated-vaccines-mrna-center-of-excellence
Hi Dan
We could all imagine but I feel a lower price would be 14-15p per share then it will increase over days/weeks once some shares become available after people take some money out to allow others in and the price will gradually increase.
That’s my thoughts anyway.
I’m no expert but would appreciate others peoples thoughts.
Anyone any idea what price this could end up when news comes in .
Am personally pleased no rns this morning (maybe later who knows)….Have a jam packed day and need to be finished in good time for the footy.
It would have been too much to cope with lol.
A bumper RNS tomoz after beating the Germans this evening would be perfect. :))
I could comment on incoming news but as a certain troll here is obsessed with having my posts removed, I really don`t think I should bother.
2% spread. Very inelastic right now.
A few good buys this morning. Need news come on Nigel its been a long wait
The SP is in such a tight range now, one piece of decent news and the rerate is going to be massive, starting to feel like my entry last week was a blinder, here’s hoping for news this week, good luck to you all.
The weeks are flying by!
It certainly is an exciting time John.
I can imagine lots of behind the scenes talks are underway and many others are interested and once one is confirmed the rest will follow.
So over the coming months I can see many contracts being signed up.
I don’t see this as a risky company anymore, we are in at the very start and have ridden the ups and downs, so once news drops I’ll open the champagne I bought about a year ago for this special announcement we will hear very soon.
Roll on the coming week(s)
So who do we think this could be?
'major international company working in the gene therapy space'
Plus it's very easy to forget the below.........
'Company continues in dialogue with other parties with a view to entering into more MTAs'
All very exciting...:)))))
Totally agree Dan
Now I’m s the time to Hold, this will multiply once news drops and those that sell before will be kicking themselves they didn’t have the patience like LTH have. GLA and enjoy the weekend and hopefully news next week.
My kinda bloke.
Can’t you just ping him a text and ask him to release it Tuesday so we have the best Tuesday ever?
It has been quiet lately Kris! All good my side, no news other than watching the Euros while waiting for Nigel to type up an RNS with some good news.
Finally a bit of chat in here.
Any news from you Delboy?
Another week ticked off
I don't think that Nigel needs to wait for the American patent to be approved Dan.
Most pharma companies are global, certainly one of the MTAs is, so to wait for a patent approval in one region doesn't make sense.
Also, once a patent is applied for, you have protection over your product already while waiting for the approval.
Dan55 I hope it is sooner than later come on Nigel lets have this nice Fat RNS
Maybe Nigel waiting for the United States Patent before making any announcement on the collaboration agreement or license
agreement.
I’ve been watching this since jan,I very rarely time it right but it can’t help feeling there’s a game changing RNS about to land...